|Agreement labeling||Portland Press – Biochemical Society|
|Has the agreement been fully disclosed and published?||No|
|Agreement period||01/01/2020 – 12/31/2022|
|Consortia / Institution||University of Arizona|
Approximate range of annual corresponding author publications
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Comments on cost development||Cost increase is minimal|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|OA publishing output is unlimited|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY variations allowed|
||Original research articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|